Development and Validation of a Nomogram to Predict the Future Risk of Cardiovascular Disease

被引:1
|
作者
Shen, Xuechun [1 ]
He, Wei [2 ]
Sun, Jinyu [3 ]
Zhang, Zuhong [1 ]
Li, Qiushuang [4 ]
Zhang, Haiyan [1 ]
Long, Mingzhi [1 ]
机构
[1] Nanjing Med Univ, Affiliated Hosp 2, Dept Cardiol, Nanjing 210011, Jiangsu, Peoples R China
[2] Nanjing Med Univ, Affiliated Hosp 2, Dept Geriatr, Nanjing 210011, Jiangsu, Peoples R China
[3] Nanjing Med Univ, Affiliated Hosp 1, Dept Cardiol, Nanjing 210029, Jiangsu, Peoples R China
[4] Nanjing Bottests Biotechnol Co Ltd, Dept Technol, Nanjing 211112, Jiangsu, Peoples R China
关键词
biomarker; cardiac myosin-binding protein -C; cardiovascular disease; nomogram; risk prediction; CORONARY-HEART-DISEASE; MULTIPLE BIOMARKERS; 10-YEAR RISK; EVENTS; MORTALITY; SCORE;
D O I
10.31083/j.rcm2402035
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Early identification of individuals at a high risk of cardiovascular disease (CVD) is crucial. This study aimed to construct a nomogram for CVD risk prediction in the general population. Methods: This retrospective study analyzed the data between January 2012 and September 2020 at the Physical Examination Center of the Second Affiliated Hospital of Nanjing Medical University (randomized 7:3 to the training and validation cohorts). The outcome was the occurrence of CVD events, which were defined as sudden cardiac death or any death related to myocardial infarction, acute exacerbation of heart failure, or stroke. The least absolute shrinkage and selection operator (LASSO) method and multivariate logistic regression were applied to screen the significant variables related to CVD. Results: Among the 537 patients, 54 had CVD (10.1%). The median cardiac myosin-binding protein-C (cMyBP-C) level in the CVD group was higher than in the no-CVD group (42.25 pg/mL VS 25.00 pg/mL, p = 0.001). After LASSO selection and multivariable analysis, cMyBP-C (Odds ratio [OR] = 1.004, 95% CI [CI, confidence interval]: 1.000-1.008, p = 0.035), age (OR = 1.023, 95% CI: 0.999-1.048, p = 0.062), diastolic blood pressure (OR =1.025, 95% CI: 0.995-1.058, p = 0.103), cigarettes per day (OR =1.066, 95% CI: 1.021-1.113, p = 0.003), and family history of CVD (OR = 2.219, 95% CI: 1.003-4.893, p = 0.047) were associated with future CVD events (p < 0.200). The model, including cMyBP-C, age, diastolic blood pressure, cigarettes per day, and family history of CVD, displayed a high predictive ability with an area under the curve (AUC) of 0.816 (95% CI: 0.714-0.918) in the training cohort (specificity and negative predictive value of 0.92 and 0.96) and 0.774 (95% CI: 0.703-0.845) in the validation cohort. Conclusions: A nomogram based on cMyBP-C, age, diastolic blood pressure, cigarettes per day, and family history of CVD was constructed. The model displayed a high predictive ability.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Development and Validation of a Nomogram for Predicting the Risk of Adverse Cardiovascular Events in Patients with Coronary Artery Ectasia
    Cai, Zhongxing
    Wang, Yintang
    Li, Luqi
    Wang, Haoyu
    Song, Chenxi
    Yin, Dong
    Song, Weihua
    Dou, Kefei
    JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE, 2021, 8 (12)
  • [42] Development and validation of a polysocial risk score for atherosclerotic cardiovascular disease
    Javed, Zulqarnain
    Valero-Elizondo, Javier
    Dudum, Ramzi
    Khan, Safi U.
    Dubey, Prachi
    Hyder, Adnan A.
    Xu, Jiaqiong
    Bilal, Usama
    Kash, Bita A.
    Cainzos-Achirica, Miguel
    Nasir, Khurram
    AMERICAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2021, 8
  • [43] Development of a Nomogram to Predict the Risk for Acute Necrotizing Pancreatitis
    Zhang, Junchao
    Weng, Xiaxia
    GUT AND LIVER, 2024, 18 (05) : 915 - 923
  • [44] Development and validation of a nomogram to predict the risk of adjacent segment disease after transforaminal lumbar interbody fusion in patients with lumbar degenerative diseases
    Yu, Miao
    Ye, Jiawen
    Xing, Hui
    Yin, Hong
    Jiang, Tao
    Liu, Minghan
    Li, Changqing
    JOURNAL OF ORTHOPAEDIC SURGERY AND RESEARCH, 2024, 19 (01):
  • [45] DNA methylation profiling to predict recurrence risk in meningioma: development and validation of a nomogram to optimize clinical management
    Nassiri, Farshad
    Mamatjan, Yasin
    Suppiah, Suganth
    Badhiwala, Jetan H.
    Mansouri, Sheila
    Karimi, Shirin
    Saarela, Olli
    Poisson, Laila
    Gepfner-Tuma, Irina
    Schittenhelm, Jens
    Ng, Ho-Keung
    Noushmehr, Houtan
    Harter, Patrick
    Baumgarten, Peter
    Weller, Michael
    Preusser, Matthias
    Herold-Mende, Christel
    Tatagiba, Marcos
    Tabatabai, Ghazaleh
    Sahm, Felix
    von Deimling, Andreas
    Zadeh, Gelareh
    Aldape, Kenneth D.
    Aldape, Kenneth
    Au, Karolyn
    Barnhartz-Sloan, Jill
    Bi, Wenya Linda
    Brastianos, Priscilla K.
    Butowski, Nicholas
    Carlotti, Carlos
    Cusimano, Michael D.
    DiMeco, Francesco
    Drummond, Katharine
    Dunn, Ian F.
    Galanis, Evanthia
    Giannini, Caterina
    Goldbrunner, Roland
    Griffith, Brent
    Hashizume, Rintaro
    Hanemann, C. Oliver
    Herold-Mende, Christel
    Horbinski, Craig
    Huang, Raymond Y.
    James, David
    Jenkinson, Michael D.
    Jungk, Christine
    Kaufman, Timothy J.
    Krischek, Boris
    Lachance, Daniel
    Lafougere, Christian
    NEURO-ONCOLOGY, 2019, 21 (07) : 901 - 910
  • [46] Development and validation of a nomogram to predict the risk factors of major complications after radical rectal cancer surgery
    Lv, Quan
    Yuan, Ye
    Qu, Shu-Pei
    Diao, Yu-Hang
    Hai, Zhan-Xiang
    Xiang, Zheng
    Peng, Dong
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [47] Validation of a Nomogram to Predict the Risk of Perioperative Blood Transfusion for Liver Resection
    Bagante, Fabio
    Spolverato, Gaya
    Ruzzenente, Andrea
    Wilson, Ana
    Gani, Faiz
    Conci, Simone
    Yahanda, Alexander
    Campagnaro, Tommaso
    Guglielmi, Alfredo
    Pawlik, Timothy M.
    WORLD JOURNAL OF SURGERY, 2016, 40 (10) : 2481 - 2489
  • [48] Validation of a Nomogram to Predict the Risk of Perioperative Blood Transfusion for Liver Resection
    Fabio Bagante
    Gaya Spolverato
    Andrea Ruzzenente
    Ana Wilson
    Faiz Gani
    Simone Conci
    Alexander Yahanda
    Tommaso Campagnaro
    Alfredo Guglielmi
    Timothy M. Pawlik
    World Journal of Surgery, 2016, 40 : 2481 - 2489
  • [49] Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study
    Hippisley-Cox, Julia
    Coupland, Carol
    Brindle, Peter
    BMJ-BRITISH MEDICAL JOURNAL, 2017, 357
  • [50] Cardiovascular disease risk factors predict the development of type 2 diabetes
    D'Agostino, RB
    Mykkanen, L
    Wagenknecht, LE
    Hamman, R
    Haffner, S
    DIABETES, 1999, 48 : A130 - A130